{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:43:04Z","timestamp":1767832984887,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.vaccine.2023.05.014","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T22:31:59Z","timestamp":1684276319000},"page":"3855-3861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6\u00a0months of age"],"prefix":"10.1016","volume":"41","author":[{"given":"Nasamon","family":"Wanlapakorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Napa","family":"Pruetarat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasiri","family":"Sarawanangkoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchana","family":"Phanphanit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donchida","family":"Srimuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaksaporn","family":"Thatsanathorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanunrat","family":"Thongmee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawarat","family":"Posuwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-6807","authenticated-orcid":false,"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.05.014_b0005","first-page":"417","article-title":"Expanded programme on immunization","volume":"92","author":"Diphtheria vaccine: WHO position paper \u2013 August 2017","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2023.05.014_b0010","unstructured":"World Health Organization. A brief history of vaccination. Available from: https:\/\/www.who.int\/news-room\/spotlight\/history-of-vaccination\/a-brief-history-of-vaccination [Accessed Date 30 January 2023]."},{"key":"10.1016\/j.vaccine.2023.05.014_b0015","first-page":"59","article-title":"Expanded programme on immunization","volume":"41","author":"Keja","year":"1988","journal-title":"World Health Stat Q"},{"key":"10.1016\/j.vaccine.2023.05.014_b0020","unstructured":"Our World in Data. Reported cases of measles, 1980 to 2021, world. Available from: https:\/\/ourworldindata.org\/grapher\/reported-cases-of-measles [Accessed Date 5 May 2023]."},{"key":"10.1016\/j.vaccine.2023.05.014_b0025","unstructured":"Our World in Data. Deaths caused by vaccine-preventable diseases, World, 2019. Available from: https:\/\/ourworldindata.org\/grapher\/deaths-caused-by-vaccine-preventable-diseases-over-time [Accessed Date 30 January 2023]."},{"key":"10.1016\/j.vaccine.2023.05.014_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150499","article-title":"The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation","volume":"11","author":"Posuwan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.05.014_b0035","series-title":"Viral Hepatitis and liver Disease","first-page":"526","article-title":"The immunogenicity and reactogenicity of combined tetravalent diphtheria, tetanus, pertussis and hepatitis B vaccine in infants","author":"Poovorawan","year":"1993"},{"key":"10.1016\/j.vaccine.2023.05.014_b0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0264-410X(02)00461-9","article-title":"Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province","volume":"21","author":"Chunsuttiwat","year":"2002","journal-title":"Thailand Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.014_b0045","unstructured":"World Health Organization (WHO). WHO - Prequalification of Medical Products (Shan-5). Product overview and package insert. Available from: https:\/\/portal-uat.who.int\/pqweb\/content\/shan-5-0 [Accessed Date 30 January 2023]."},{"key":"10.1016\/j.vaccine.2023.05.014_b0050","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1016\/j.vaccine.2009.08.034","article-title":"Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination","volume":"27","author":"Tharmaphornpilas","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.014_b0055","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.vaccine.2019.12.065","article-title":"Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth","volume":"38","author":"Posuwan","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.014_b0060","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1016\/j.vaccine.2020.08.058","article-title":"Levels of antibodies specific to diphtheria toxoid, tetanus toxoid, and Haemophilus influenzae type b in healthy children born to Tdap-vaccinated mothers","volume":"38","author":"Wanlapakorn","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.014_b0065","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/cid\/ciz778","article-title":"Quantity and quality of antibodies after acellular versus whole-cell pertussis vaccines in infants born to mothers who received tetanus, diphtheria, and acellular pertussis vaccine during pregnancy: a randomized trial","volume":"71","author":"Wanlapakorn","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.05.014_b0070","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.vaccine.2020.01.040","article-title":"Seroprotection rate in adults after 1-dose, 2-dose, and 3-dose series of a reduced-diphtheria-tetanus toxoid vaccine (Td) during a diphtheria outbreak in Thailand","volume":"38","author":"Suntarattiwong","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.014_b0075","first-page":"53","volume":"92","author":"Tetanus vaccines: WHO position paper \u2013 February 2017","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2023.05.014_b0080","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1440-1746.2000.0150121356.x","article-title":"Chronic hepatitis B virus infection in Asian countries","volume":"15","author":"Merican","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2023.05.014_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1086\/599331","article-title":"Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers","volume":"200","author":"Poovorawan","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.05.014_b0090","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1016\/j.vaccine.2007.06.059","article-title":"Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years","volume":"25","author":"Hammitt","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.014_b0095","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.inf.0000130952.96259.fd","article-title":"Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth","volume":"23","author":"Petersen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.05.014_b0100","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1542\/peds.2007-0131","article-title":"Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy","volume":"120","author":"Samandari","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2023.05.014_b0105","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4161\/hv.19989","article-title":"Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers","volume":"8","author":"Poovorawan","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.05.014_b0110","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4161\/hv.24844","article-title":"Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand","volume":"9","author":"Poovorawan","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.05.014_b0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose","volume":"214","author":"Bruce","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.05.014_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep."},{"issue":"44","key":"10.1016\/j.vaccine.2023.05.014_b0125","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1016\/j.vaccine.2012.07.088","article-title":"Development and introduction of a ready-to-use pediatric pentavalent vaccine to meet and sustain the needs of developing countries\u2013Quinvaxem\u00ae: the first 5 years","volume":"30","author":"Schmid","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.014_b0130","first-page":"753","article-title":"Immunogenicity and safety of Quinvaxem (Diphtheria, tetanus, whole-cell pertussis, hepatitis B and Haemophilus influenzae type b vaccine) given to Vietnamese infants at 2 to 4 months of age","volume":"46","author":"Huu","year":"2015","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2023.05.014_b0135","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1097\/INF.0000000000001682","article-title":"A randomized controlled study of a fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccinations of healthy infants and toddlers in Latin America","volume":"36","author":"L\u00f3pez","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.014_b0140","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/hv.5.6.7816","article-title":"A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (liq) and TritanrixHB + Hiberix (lyo) in Indian infants administered according to the EPI schedule","volume":"5","author":"Rao","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2023.05.014_b0145","unstructured":"World Health Organization. WHO recommendations for routine immunization - summary tables. Available from: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/policies\/who-recommendations-for-routine-immunization---summary-tables [Accessed Date 3 May 2023]."},{"key":"10.1016\/j.vaccine.2023.05.014_b0150","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/INF.0b013e318242460a","volume":"31","author":"Tregnaghi","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.05.014_b0155","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00006454-200110000-00011","article-title":"Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants","volume":"20","author":"Yeh","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.05.014_b0160","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0264-410X(98)00402-2","article-title":"Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children","volume":"17","author":"Richie","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.014_b0165","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1016\/j.vaccine.2017.08.056","article-title":"Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adults","volume":"35","author":"van der Heiden","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.014_b0170","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants","volume":"27","author":"P\u00f6llabauer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.05.014_h9010","doi-asserted-by":"crossref","first-page":"406","DOI":"10.15585\/mmwr.mm7111a2","article-title":"Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination - Worldwide, 2000\u20132020","volume":"71","author":"Kanu","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.vaccine.2023.05.014_h0175","unstructured":". ."},{"key":"10.1016\/j.vaccine.2023.05.014_h9015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.vaccine.2023.05.014_h0180","unstructured":". ."},{"key":"10.1016\/j.vaccine.2023.05.014_b0185","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/INF.0000000000001601","article-title":"Pneumococcal Immune Response in Infants Whose Mothers Received Tetanus, Diphtheria and Acellular Pertussis Vaccination During Pregnancy","volume":"36","author":"Maertens","year":"2017","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23005418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23005418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:25:48Z","timestamp":1759404348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23005418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":39,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0264410X23005418"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6\u00a0months of age","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}